Søgning på udtrykket 'pneumoni' giver 61 resultater
Dokumenter [6] Sider [3] Kalender [11] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [6]
1. udgave, forventes opdateret i løbet af 2022. Retningslinjerne er udarbejdet af en arbejdsgruppe med repræsentanter fra Dansk Lungemedicinsk Selskab og Dansk Selskab for Infektionsmedicin.
Version 8 (21.11.22) Udarbejdet af Dansk Selskab for Infektionsmedicin i samarbejde med Dansk Selskab for Klinisk Mikrobiologi, Dansk Hæmatologisk Selskab, Dansk Pædiatrisk Selskab, Dansk Selskab for Almen Medicin, Dansk Lungemedicinsk Selskab, Dansk Selskab for Obstetrik og Gynækologi, Dansk Transplantationsselskab, Dansk Selskab for Klinisk Onkologi & Fagligt Selskab for Hygiejnesygeplejersker
Ændringer siden version 28: Moderat risikogruppe udgår. Gravide udgår som risikogruppe. Skærpelse af kriterier for opstart af Paxlovid (nu kun højrisiko patient med indikation).
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: Remdesivir står ikke længere som relativt kontraindiceret ved påvirket nyrefunktion.
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: 1. Et af Paxlovid kriterierne ændret (fra ”Betydelige symptomer på COVID-19” til ”Mild eller moderat COVID-19”). 2. Døde links til infektionshygiejniske retningslinjer er fjernet, og nyt er indsat. 3. Tekst om afisolation.
Ændringer siden sidste udgave: 1. Simplificering af risikogrupper. 2. Skærpelse af kriterier for opstart af behandling hos indlagte patienter, f.eks. blodgas analyse før remdesivir. 3. Information om høj pris på paxlovid og højere NNT for beskyttelse mod alvorligt forløb siden primærpublikation.
Sider [3]
… Wiese. Osteomyelitis: Nis Pedersen Jørgensen (tovholder), Nina Weis, Terese Katzenstein, Pernille Ravn, Lotte Ebdrup, Iben Ørsted, Theis Aagaard og Michala Kehler Guidelines for diagnostik og behandling af spondylodiskitis, Pneumoni: Christian Philip Fischer (tovholder), Sebastian Von Huth, Klaus Leth Mortensen, Birgitte Lindegaard Madsen, Lone Mygind, Camilla Hatleberg, Thomas Benfield Pneumoni, Rationel antibiotikaanvendelse: Trine Langfeldt Hagen (tovho…
Risikoen for bakteriel infektion og sepsis er svært forhøjet ved manglende miltfunktion som følge af splenektomi samt kongenit eller funktionel aspleni. Alvorlige infektioner skyldes primært Streptococcus pneumoniae, Haemophilus influenzae og Neisseria meningitidis. Risikoen for svær infektion ved malaria og dyrebid er også markant forhøjet. Vaccination, antibiotika profylakse/tidlig behandling og adækvat patient information er afgørende for forebyggelse af infektioner. Antibiotika behandlin…
…cu Johansen. 13.45-14.45. Lunge absces, empyem og Aspergillus. Formaliserede indlæg. Plenumdiskussion. Christian Laursen. 14.45-15.00. Pause. . . 15.00-16.00. Non-infektiøse pneumonier. Formaliserede indlæg. Plenumdiskussion. Jesper Davidsen. 16.00-16.15. Opsamling og evaluering. . Anbefalet læsning: TB og non-tuberkuløse mykobakterier. "Tuberkulose - diagnostik og beha…
…ndgrens studie af, hvornår man kan holde op med at give pneumocyste-profylakse til HIV-smittede eller de Gans studiet, der ændrede fik indført dexamethason i retningslinjerne for purulent meningitis. Her er formentlig et nyt studie, der kommer til at få indflydelse på standardbehandlingen af patienter med svær pneumoni. Læs en gang - og døm selv - jeg tager den med til næste års "Journal Highlights of the year", men tænkte at den måske allerede nu var god at få kendskab til. God læselyst :-)
Kalender [11]
17. maj 2026, København
21. marts, Fredericia
17. marts, Online og Cape Town, Sydafrika
10. maj 2023, Mærsk Tårnet, Panum Instituttet
6. maj 2022, Hindsgavl, Middelfart
16. juni 2021, Online
26. november 2018, Liverpool, England
9. november 2018, Korsør
12. oktober 2018, Nordsjællands Hospital Hillerød
9. marts 2018, Auditoriet, Nordsjællands Hospital Hillerød
2. april 2014, Cape Town, Sydafrika
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Infection
23.07.2024
… Abstract. . Purpose. This study assessed the frequency, clinical significance, and risk factors for Herpes simplex virus (HSV) reactivation in immunocompetent patients with community-acquired pneumonia (CAP). . . . Methods. The study included adult CAP-patients who were enrolled in the CAPNETZ study between 2007 and 2017 and had a residual sputum sample available for a…
Infection
22.07.2024
… Abstract. . Purpose. This study assessed the frequency, clinical significance, and risk factors for Herpes simplex virus (HSV) reactivation in immunocompetent patients with community-acquired pneumonia (CAP). . . . Methods. The study included adult CAP-patients who were enrolled in the CAPNETZ study between 2007 and 2017 and had a residual sputum sample available for a…
Infection
21.07.2024
. Abstract. . Purpose. Daptomycin-induced eosinophilic pneumonia (DIEP) is a rare yet severe adverse event that requires rapid recognition and management. Diagnosing a definite case is challenging and involves meeting the American Thoracic Society (ATS) criteria, although alternative criteria have been suggested. This study aims to conduct a systematic review of literature and includes a case series. . . …
Infection
20.07.2024
. Abstract. . Purpose. Daptomycin-induced eosinophilic pneumonia (DIEP) is a rare yet severe adverse event that requires rapid recognition and management. Diagnosing a definite case is challenging and involves meeting the American Thoracic Society (ATS) criteria, although alternative criteria have been suggested. This study aims to conduct a systematic review of literature and includes a case series. . . …
BMC Infectious Diseases
20.07.2024
. Abstract. . Background. K. pneumoniae liver abscess (KPLA) mostly involves the right lobe. We present a case of K. pneumoniae caudate liver abscess with invasive liver abscess syndrome (ILAS) was rarely identified. . . . Case presentation. A 53-year-old man with elevated glycated hemoglobin with chills, rigors and a fever of five days. The…
BMC Infectious Diseases
19.07.2024
. Abstract. . Background. The prevalence and severity of pediatric Mycoplasma pneumoniae pneumonia (MPP) poses a significant threat to the health and lives of children. In this study, we aim to systematically evaluate the value of routine blood parameters in predicting MPP and develop a robust and generalizable ensemble artificial intelligence (AI) model to assist in identifying patients with MPP. . . …
Clinical Infectious Diseases
18.07.2024
Abstract . Introduction . Understanding the pneumococcal serotypes causing community-acquired pneumonia (CAP) is essential for evaluating the impact of pneumococcal vaccines.Methods . We conducted a prospective surveillance study of adults aged ≥18 years hospitalized with CAP at 3 hospitals in Tennessee and Georgia between 1 September 2018 and 31 October 2022. We assessed for pneumococcal etiology with cultures, the BinaxNOW urinary antigen detection test, and serotype-specific urinary antigen detection a…
PLoS One Infectious Diseases
17.07.2024
…e bacteria that are harmful to the host. Meanwhile, some phages from the environment might affect non-pathogenic bacteria for the host. Methods Here, bacteriophages isolated from mouse feces were intratracheally (IT) or intravenously (IV) administered in pneumonia mice caused by Pseudomonas aeruginosa at 2 hours post-intratracheal bacterial administration. As such, the mice with phage treatment, using either IT or IV administration, demonstrated less severe pneumonia as indicated by mortality, serum cytoki…
Antimicrobial Agents And Chemotherapy
12.07.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
Clinical Microbiology and Infection
12.07.2024
We aimed to assess the performance of common pneumonia severity scores, including Pneumonia Severity Index (PSI), CURB-65, CRB-65, A-DROP and SMART-COP, in predicting adverse outcomes in an elderly community-acquired pneumonia (CAP) cohort and to determine the optimal scoring system for specific outcomes of interest.
Emerg Microbes Infect
11.07.2024
Volume 13, Issue 1, December 2024 .
Infection
10.07.2024
Infection
10.07.2024
. Abstract. Immunosuppression constitutes a significant risk for community-acquired pneumonia (CAP). Nevertheless, specific causes of immunosuppression and their relevance for incidence, etiology and prognosis of CAP are insufficiently investigated. . We conducted a population-based cohort study within a statutory health insurance in Germany from 2015 to 2018. CAP was retrieved by ICD-10-GM codes. Episodes of immunosuppression were identified by coded c…
BMJ Open
9.07.2024
. Objective. In order to predict at hospital admission the prognosis of patients with serious and life-threatening COVID-19 pneumonia, we sought to understand the clinical characteristics of hospitalised patients at admission as the SARS-CoV-2 pandemic progressed, document their changing response to the virus and its variants over time, and identify factors most importantly associated with mortality after hospital admission. . Design. Observational study using a prospective hospital systemwide COVID-19 dat…
Critical Care Explorations
9.07.2024
IMPORTANCE: . Ventilator-associated pneumonia (VAP) frequently occurs in patients with cardiac arrest. Diagnosis of VAP after cardiac arrest remains challenging, while the use of current biomarkers such as C-reactive protein (CRP) or procalcitonin (PCT) is debated. OBJECTIVES: . To evaluate biomarkers’ impact in helping VAP diagnosis after cardiac arrest. DESIGN, SETTING, AND PARTICIPANTS: . This is a prospective ancillary study of the randomized, multicenter, double-blind placebo-controlled ANtibiothe…
International Journal of Infectious Diseases
7.07.2024
…(ACTIV) initiative, a randomized, double-blind, placebo-controlled clinical trial was conducted to investigate the safety and efficacy of 3 immunomodulatory agents—infliximab, abatacept, and cenicriviroc—in treating patients hospitalized with COVID-19 pneumonia [1]. The patient's daily clinical status was assessed on an 8-point ordinal scale: 1, death; 2, hospitalized, on invasive mechanical ventilation or ECMO; 3, hospitalized, on non-invasive ventilation or high flow oxygen devices; 4, hospitalized, r…
International Journal of Infectious Diseases
4.07.2024
Although the prevalence of COVID-19 pneumonia has decreased since the less virulent omicron variant became dominant,[1] it is still the leading cause of COVID-19-related death. As COVID-19 now becomes an endemic disease, omicron reinfection is increasingly common due to emerging sub-variants and loosening policies.[2] Studies have shown that pre-omicron SARS-CoV-2 infection could protect against severe COVID-19 during reinfection.[3,4] However, pneumonia history was associated with increased risk of pneumon…
BMJ Open
4.07.2024
. Introduction. Non-ventilator-associated hospital-acquired pneumonia (nv-HAP) is the most common healthcare-associated infection (HCAI), is associated with high mortality and morbidity and places a major burden on healthcare systems. Diagnosis currently relies on chest x-rays to confirm pneumonia and sputum cultures to determine the microbiological cause. This approach leads to over-diagnosis of pneumonia, rarely identifies a causative pathogen and perpetuates unnecessary and imprecise antibiotic use. The …
BMC Infectious Diseases
4.07.2024
. Abstract. . Background. An improper host immune response to Mycoplasma pneumoniae generates excessive inflammation, which leads to the impairment of pulmonary ventilation function (PVF). Azithromycin plus inhaled terbutaline has been used in the treatment of Mycoplasma pneumoniae pneumonia (MPP) in children with impaired pulmonary function, but previous randomized controlled trials (RCTs) showed inconsistent efficacy and s…
International Journal of Infectious Diseases
4.07.2024
… identified in 2001 [1], and is genetically similar to respiratory syncytial virus [1]. While hMPV commonly causes respiratory infection in children, older individuals and adults with a medical history of respiratory disease can also be infected [2]. Respiratory infection due to hMPV accounts for 2.2–10.5% of all respiratory infections, most commonly in winter [3]. In the United States, hMPV is reportedly the fourth-most common cause of community-acquired pneumonia requiring hospitalization in adults [4].
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Medscape Infectious Diseases
5.07.2024
Specific antipsychotics prescribed in high doses were linked to an increased risk for pneumonia in patients with schizophrenia, new research showed. . Medscape Medical News
Medscape Infectious Diseases
9.05.2024
Researchers examined time to clinical stability in 571 children hospitalized with community-acquired pneumonia. . Medscape Medical News
Eurosurveillance latest updates
19.04.2024
In 2023, an increase of OXA-48-producing Klebsiella pneumoniae was noticed by the Lithuanian National Public Health Surveillance Laboratory. Whole genome sequencing (WGS) of 106 OXA-48-producing K. pneumoniae isolates revealed three distinct clusters of carbapenemase-producing K. pneumoniae high-risk clones, including sequence type (ST) 45 (n = 35 isolates), ST392 (n = 32) and ST395 (n = 28), involving six, six and nine hospitals in different regions, respectively. These results enabled targeted…
Morbidity and Mortality Weekly Report (MMWR)
22.02.2024
This report describes an increase in Mycoplasma pneumoniae, a common cause of respiratory illness, beginning in fall 2023.
Medscape Infectious Diseases
15.02.2024
The ECDC has called for mitigating actions in the face of more European Union and European Economic Area countries reporting hypervirulent Klebsiella pneumoniae ST23. . Medscape Medical News
Medscape Infectious Diseases
26.01.2024
Exblifep is as effective as piperacillin-tazobactam in the treatment of complicated urinary tract infections, the European Medicines Agency said. . Medscape Medical News
Eurosurveillance latest updates
26.01.2024
Mycoplasma pneumoniae is an important cause of pneumonia and extra-pulmonary manifestations. We observed a rise in admissions due to M. pneumoniae infections starting October 2023 in a regional hospital in the Netherlands and an increased incidence in national surveillance data. The incidence in the Netherlands has not been that high since 2011. The patients had a lower median age compared with 2019 and 2020 (28 vs 40 years). M. pneumoniae should be considered in patients with respiratory symptoms, especial…
Eurosurveillance latest updates
12.01.2024
We report a surge of patients, especially children and adolescents, with respiratory disease caused by Mycoplasma pneumoniae in Denmark since October 2023. While the surge has reached an epidemic level, no impact on hospital capacity has been observed; only 14% (446/3,195) of cases, primarily adults, required hospitalisation. Macrolide resistance was detected in less than 2% of samples tested. Timely monitoring of hospitalisations linked to M. pneumoniae infections has been established to inform the healthc…
Eurosurveillance latest updates
24.11.2023
. Background. Preliminary unpublished results of the survey of carbapenem- and/or colistin-resistant Enterobacterales (CCRE survey) showed the expansion of carbapenemase-producing Klebsiella pneumoniae (CPKP) sequence type (ST) 39 in 12 of 15 participating Greek hospitals in 2019. . . Aim. We conducted a rapid survey to determine the extent of spread of CPKP high-risk clones in Greek hospitals in 2022 and compare the distribution of circulating CPKP clones in these hospitals since 2013. . . Methods. We …
Eurosurveillance latest updates
20.10.2023
. Background. Since 2021, an emergence of New Delhi metallo-β-lactamase (NDM)-14-producing Klebsiella pneumoniae has been identified in France. This variant with increased carbapenemase activity was not previously detected in Enterobacterales. . . Aim. We investigated the rapid dissemination of NDM-14 producers among patients in hospitals in France. . . Methods. All NDM-14-producing non-duplicate clinical isolates identified in France until June 2022 (n = 37) were analysed by whole genome sequencin…
Eurosurveillance latest updates
20.10.2023
New Delhi metallo-beta-lactamase (NDM)-producing Klebsiella pneumoniae (Kp) ST147 caused a large multi-hospital outbreak in Italy from 2018 to 2021. We describe a new ST6668 NDM-producing Kp clone, belonging to CC147, which rapidly spread across hospitals in the Pavia province (Northern Italy) from February to August 2023. Genomic analyses revealed that ST6668 is different from ST147 and fast evolving. As shown here, genomic surveillance programmes are useful for tracking the spread of new clones with reduc…
Medscape Infectious Diseases
26.09.2023
New research from Northwestern University and the University of Wisconsin, however, is pointing to bacterial pneumonia as the cause of many severe COVID deaths. . WebMD Health News
Medscape Infectious Diseases
19.09.2023
Clinicians should consider all three etiologies on community-acquired pneumonia presentation to improve antimicrobial stewardship and patient outcomes. . CDC Expert Commentary
ProMED
13.05.2023
Pneumonia -- IraqFollowing a surge in meningitis cases in Halabjah City and Sulaymaniyah governorate since mid-April 2023, an expert team from the World Health Organization (WHO) and the Ministry of Health was deployed to the affected areas to perform a joint epidemiological investigation of the reported cases and develop a swift response plan to curb the transmission of the disease.Preliminary laboratory results from 24 collected samples showed a mixture of bacterial (_Streptococcus pneumoniae_) and viral
ProMED
7.05.2023
…fection -- United StatesA bacterial outbreak at Virginia Mason Medical Center in Seattle has sickened 31 patients since October [2022]. Seven of them have since died, but it's unknown what caused those deaths -- the infection or the diagnoses that brought them to the hospital in the first place._Klebsiella pneumoniae_ is a bacterium usually found in health care settings, and often resistant to antibiotics. It can cause pneumonia, meningitis, and wound or bloodstream infections.Virginia Mason is working with
ProMED
28.04.2023
Klebsiella pneumoniae -- United StatesFour patients at a downtown Seattle hospital are dead in connection to an outbreak of a bacterium often found in healthcare settings that has developed resistance to some antibiotics.The [31] infected patients, who contracted _Klebsiella_, were hospitalized in various departments, including inpatient medical beds, an ICU, and an operating room at Virginia Mason Medical Center, the hospital said in a statement released Wednesday [26 Apr 2023].Beginning in October 2022, h…
Eurosurveillance latest updates
28.04.2023
A hypervirulent Klebsiella pneumoniae SL218 (ST23-KL57), phylogenetically distinct from the classical hypervirulent SL23 (ST23-KL1) lineage, was transmitted between hospitalised patients in Denmark in 2021. The isolate carried a hybrid resistance and virulence plasmid containing blaNDM-1 and a plasmid containing blaOXA-48 (pOXA-48); the latter plasmid was horizontally transferred within-patient to Serratia marcescens. The convergence of drug resistance and virulence factors in single plasmids and in differe…
Eurosurveillance latest updates
15.12.2022
In 2022, German surveillance systems observed rapidly increasing numbers of NDM-1- and NDM-1/OXA-48-producing Klebsiella pneumoniae, which may in part reflect recurring pre-pandemic trends. Among these cases, however, a presence in Ukraine before diagnosis was frequently reported. Whole genome sequencing of 200 isolates showed a high prevalence of sequence types ST147, ST307, ST395 and ST23, including clusters corresponding to clonal dissemination and suggesting onward transmission in Germany. Screening and…
Eurosurveillance latest updates
10.11.2022
…allow identification of novel bacterial species. This can affect surveillance of infections and antimicrobial resistance. From 2017, increasing numbers of medical microbiology laboratories in Switzerland differentiated Klebsiella variicola from Klebsiella pneumoniae complex using updated MALDI-TOF databases, whereas many laboratories still report them as K. pneumoniae or K. pneumoniae complex. Aim. Our study explored whether separate reporting of K. variicola and the Klebsiella pneumoniae complex affected t…
ProMED
31.10.2022
Hospital-Related Infection -- Jamaica